This company is no longer active
Zosano Pharma Dividende
Zukünftiges Wachstum Kriterienprüfungen 0/6
Wichtige Informationen
n/a
Dividendenausschüttung
n/a
Ausschüttungsquote
Durchschnittlicher Branchenertrag | 1.7% |
Nächster Dividendenzahlungstermin | n/a |
Ex-Dividendendatum | n/a |
Dividende pro Aktie | n/a |
Gewinn pro Aktie | -US$11.26 |
Prognose der Dividendenrendite | n/a |
Aktuelle Dividendenentwicklung
Keine Aktualisierungen
Recent updates
Can Zosano Pharma (NASDAQ:ZSAN) Afford To Invest In Growth?
Nov 02Is Zosano Pharma (NASDAQ:ZSAN) Weighed On By Its Debt Load?
Jun 29Data supports long-term benefit of Zosano's migraine candidate; shares surge 23%
May 26Zosano Pharma: Early PK+Safety Study In Q3 2021 May Breathe New Life Into This Biotech
Apr 30Zosano shares rise on migraine treatment NDA resubmission update
Apr 26Auditors Have Doubts About Zosano Pharma (NASDAQ:ZSAN)
Mar 15Zosano Pharma up 21% following FDA feedback on Qtrypta application; presents Qtrypta data in migraine
Feb 01Zosano Pharma requests FDA meeting for its Qtrypta application
Jan 04Zosano Pharma EPS misses by $0.01
Nov 13Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: Insufficient data to determine if ZSAN.Q's dividends per share have been stable in the past.
Wachsende Dividende: Insufficient data to determine if ZSAN.Q's dividend payments have been increasing.
Dividendenrendite im Vergleich zum Markt
Zosano Pharma Dividendenrendite im Vergleich zum Markt |
---|
Segment | Dividendenrendite |
---|---|
Unternehmen (ZSAN.Q) | n/a |
Untere 25 % des Marktes (US) | 1.4% |
Markt Top 25 % (US) | 4.3% |
Branchendurchschnitt (Medical Equipment) | 1.7% |
Analystenprognose (ZSAN.Q) (bis zu 3 Jahre) | n/a |
Bemerkenswerte Dividende: Unable to evaluate ZSAN.Q's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hohe Dividende: Unable to evaluate ZSAN.Q's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Unable to calculate sustainability of dividends as ZSAN.Q has not reported any payouts.